We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Federated Hermes Short Duration Corporate ETF
FCSH
$66.6M
| $23.8M | 0.05% |
990,004
| – | – |
|
402
Teladoc Health
TDOC
$1.2B
| $23.7M | 0.05% |
329,206
+143,398
| +77% | +$10.3M |
|
|
FUSN
403
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $23.7M | 0.05% |
3,055,037
+1,481,037
| +94% | +$10.7M |
|
404
Take-Two Interactive
TTWO
$39.6B
| $23.7M | 0.05% |
153,950
-2,132
| -1% | -$341K |
|
405
Penumbra
PEN
$12.5B
| $23.6M | 0.05% |
106,368
+86
| +0.1% | +$19.1K |
|
406
Alibaba
BABA
$272B
| $23.5M | 0.05% |
215,975
-109,087
| -34% | -$12.6M |
|
407
Yum! Brands
YUM
$38.4B
| $23.5M | 0.05% |
198,109
-69,262
| -26% | -$8.53M |
|
|
AQUA
408
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $23M | 0.05% |
490,426
+467,848
| +2,072% | +$20M |
|
409
Live Nation Entertainment
LYV
$39.7B
| $23M | 0.05% |
195,519
-24,185
| -11% | -$2.76M |
|
410
AMC Global Media
AMCX
$503M
| $22.7M | 0.05% |
557,821
-85,957
| -13% | -$3.47M |
|
|
NSTG
411
DELISTED
NanoString Technologies, Inc.
NSTG
| $22.6M | 0.05% |
649,888
-22,931
| -3% | -$790K |
|
412
Paychex
PAYX
$42.1B
| $22.4M | 0.05% |
164,383
+20,509
| +14% | +$2.52M |
|
413
Cushman & Wakefield Ltd
CWK
$2.94B
| $22.3M | 0.05% |
1,087,308
+951,914
| +703% | +$20.2M |
|
414
Allegion
ALLE
$13.1B
| $22.3M | 0.05% |
202,802
-23,301
| -10% | -$2.76M |
|
415
Expeditors International
EXPD
$25.2B
| $22.2M | 0.05% |
215,248
+195,588
| +995% | +$21.6M |
|
416
Alcoa
AA
$12.3B
| $22M | 0.05% |
244,734
-161,983
| -40% | -$11.8M |
|
417
Braze
BRZE
$2.89B
| $22M | 0.05% |
530,000
| – | – |
|
418
Hewlett Packard
HPE
$74.2B
| $22M | 0.05% |
1,313,958
-12,263
| -0.9% | -$206K |
|
419
Portland General Electric
POR
$5.58B
| $21.8M | 0.05% |
395,750
+49,795
| +14% | +$2.62M |
|
420
StoneCo
STNE
$2.23B
| $21.8M | 0.05% |
1,862,323
+1,408,248
| +310% | +$18.4M |
|
421
ICU Medical
ICUI
$3.9B
| $21.4M | 0.05% |
96,154
-28,447
| -23% | -$6.37M |
|
422
CS Disco
LAW
$280M
| $21.4M | 0.05% |
630,145
-177,802
| -22% | -$5.83M |
|
|
MRTX
423
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.3M | 0.05% |
259,207
+359
| +0.1% | +$36.7K |
|
|
GMDA
424
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $21.3M | 0.05% |
5,128,300
+764,985
| +18% | +$2.56M |
|
425
Red Rock Resorts
RRR
$3.18B
| $21.3M | 0.05% |
438,055
-173,578
| -28% | -$8.28M |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.